# ENDRA Life Sciences Inc.: insider transactions

NDRA · Nasdaq · CIK 1681682 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ndra.md) · [Financials](/companies/ndra/financials.md) · [Filings](/companies/ndra/filings.md) · [Insiders](/companies/ndra/insiders.md)

## All transactions: 2

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2024-08-27 | [UBS Group AG](/insiders/1610520.md) | 10% owner | Purchase (P) | 3,715 | $0.5523 | $2.1k | [Form 4](/filings/0001610520-24-000151.md) |
| 2024-08-27 | [UBS Group AG](/insiders/1610520.md) | Market maker/broker-dealer | Purchase (P) | 0 | $0.00 | $0 | [Form 4/A](/filings/0001610520-24-000153.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 26, 2026, 16:17 ET. No prices; not investment advice.